Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 560 equity shares (face value Rs. 10 each) through the open market on December 8, 2025. This represents a 0.02% increase in its holding, taking its stake from 29,990 shares (1.00%) to 30,550 shares (1.02%) of the company. The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The total equity share capital of Ishita Drugs & Industries remains unchanged at 29,90,300 shares worth Rs. 2.99 crore. The acquisition is minor and incremental in nature.
This is a small, incremental purchase by a related party showing continued confidence in the company, but with negligible impact on overall shareholding pattern or stock price given the tiny 0.02% change.